/Unitedhealth%20Group%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
In an election year, Washington, D.C. focused on Medicare Advantage oversight, and UnitedHealth Group (UNH) has become a prime target. Senators Elizabeth Warren and Ron Wyden have escalated their investigation into the company’s nursing home practices after reports and whistleblower claims that some seniors allegedly died when hospital transfers were delayed or denied under UnitedHealth-linked Medicare plans.
At the same time, federal agencies are tightening audits of Medicare Advantage contracts and billing, signaling a tougher line on private insurers' managed care and reimbursement for vulnerable patients. This scrutiny comes as UNH shares, while recovering some ground after a difficult 2025, still trade about 34% below their 52‑week high.
